160 related articles for article (PubMed ID: 28740360)
1. Visual processing in patients with age-related macular degeneration performing a face detection test.
Vottonen P; Kaarniranta K; Pääkkönen A; Tarkka IM
Clin Ophthalmol; 2017; 11():1245-1252. PubMed ID: 28740360
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Age-Related Macular Degeneration on Components of Face Perception.
Logan AJ; Gordon GE; Loffler G
Invest Ophthalmol Vis Sci; 2020 Jun; 61(6):38. PubMed ID: 32543666
[TBL] [Abstract][Full Text] [Related]
3. Best-corrected visual acuity and retinal thickness are associated with improved cortical visual processing in treated wet AMD patients.
Vottonen P; Pääkkönen A; Tarkka IM; Kaarniranta K
Acta Ophthalmol; 2015 Nov; 93(7):621-5. PubMed ID: 26031317
[TBL] [Abstract][Full Text] [Related]
4. A Prospective Observational Study on Clinical Profile and Visual Outcomes in Neovascular Age-Related Macular Degeneration.
Dalai R; Bedant SS; Rout R; Panda BB
Cureus; 2024 Jan; 16(1):e52731. PubMed ID: 38384637
[TBL] [Abstract][Full Text] [Related]
5. Baseline characteristics and progression of neovascular age-related macular degeneration in patients receiving over 60 intravitreal injections of anti-vascular endothelial growth factor.
Prahs P; Brandl C; Helbig H; Volz C
Rom J Ophthalmol; 2023; 67(3):260-266. PubMed ID: 37876508
[No Abstract] [Full Text] [Related]
6. Monocular and Binocular Visual Function Assessments and Activities of Daily Living Performance in Age-Related Macular Degeneration.
Peterson CL; Yap CL; Tan TF; Tan LLY; Sim KT; Ong L; Tan ZK; Tan YW; Man R; Fenwick E; Cheung G; Lamoureux E; Tan ACS
Ophthalmol Retina; 2024 Jan; 8(1):32-41. PubMed ID: 37648064
[TBL] [Abstract][Full Text] [Related]
7. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
Solomon SD; Lindsley K; Vedula SS; Krzystolik MG; Hawkins BS
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD005139. PubMed ID: 30834517
[TBL] [Abstract][Full Text] [Related]
8. TEN-YEAR FOLLOW-UP OF PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS.
Starr MR; Kung FF; Mejia CA; Bui YT; Bakri SJ
Retina; 2020 Sep; 40(9):1665-1672. PubMed ID: 31725524
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Follow-up of Patients with Exudative Age-Related Macular Degeneration Treated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
Kung FF; Starr MR; Bui YT; Mejia CA; Bakri SJ
Ophthalmol Retina; 2020 Nov; 4(11):1047-1053. PubMed ID: 32439455
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
Retina; 2007; 27(4):432-8. PubMed ID: 17420694
[TBL] [Abstract][Full Text] [Related]
11. Effects of face inversion on the structural encoding and recognition of faces. Evidence from event-related brain potentials.
Eimer M
Brain Res Cogn Brain Res; 2000 Sep; 10(1-2):145-58. PubMed ID: 10978702
[TBL] [Abstract][Full Text] [Related]
12. Vitreomacular Interface after Anti-Vascular Endothelial Growth Factor Injections in Neovascular Age-Related Macular Degeneration.
Veloso CE; Kanadani TM; Pereira FB; Nehemy MB
Ophthalmology; 2015 Aug; 122(8):1569-72. PubMed ID: 26038338
[TBL] [Abstract][Full Text] [Related]
13. The effect of non-neovascular age-related macular degeneration on face recognition performance.
Taylor DJ; Smith ND; Binns AM; Crabb DP
Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):815-821. PubMed ID: 29484559
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetic influence of LOC387715/HTRA1 on the efficacy of bevacizumab treatment for age-related macular degeneration in a Korean population.
Kang HK; Yoon MH; Lee DH; Chin HS
Korean J Ophthalmol; 2012 Dec; 26(6):414-22. PubMed ID: 23204795
[TBL] [Abstract][Full Text] [Related]
15. One-year outcomes of less frequent bevacizumab in age-related macular degeneration.
Sonmez K; Sonmez PA; Ozkan SS; Atmaca LS
Retina; 2011 Apr; 31(4):645-53. PubMed ID: 21358363
[TBL] [Abstract][Full Text] [Related]
16. EFFICACY OF ADJUVANT TOPICAL DORZOLAMIDE-TIMOLOL IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION REFRACTORY TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
Lee JH; Lee SC; Byeon SH; Koh HJ; Kim SS; Lee CS
Retina; 2019 Oct; 39(10):1953-1958. PubMed ID: 30161096
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal anti-vascular endothelial growth factor for typical exudative age-related macular degeneration in eyes with good baseline visual acuity.
Chang YS; Han JI; Yoo SJ; Lew YJ; Kim JH
Korean J Ophthalmol; 2014 Dec; 28(6):466-72. PubMed ID: 25435749
[TBL] [Abstract][Full Text] [Related]
18. Alternating Bi-Weekly Intravitreal Ranibizumab and Bevacizumab for Refractory Neovascular Age-Related Macular Degeneration with Pigment Epithelial Detachment
Witkin AJ; Rayess N; Garg SJ; Maguire JI; Storey P; Kaiser RS; Hsu J; Vander JF; Ho AC
Semin Ophthalmol; 2017; 32(3):309-315. PubMed ID: 26337539
[TBL] [Abstract][Full Text] [Related]
19. Real-World Treatment Outcomes of Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in Asians.
Fenner BJ; Ting DSW; Tan ACS; Teo K; Chan CM; Mathur R; Yeo IYS; Wong TY; Wong EYM; Cheung CMG
Ophthalmol Retina; 2020 Apr; 4(4):403-414. PubMed ID: 31953109
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study.
Banister K; Cook JA; Scotland G; Azuara-Blanco A; Goulão B; Heimann H; Hernández R; Hogg R; Kennedy C; Sivaprasad S; Ramsay C; Chakravarthy U
Health Technol Assess; 2022 Jan; 26(8):1-142. PubMed ID: 35119357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
